Epigenetic silencing of the MGMT (O6-methylguanine DNA methyltransferase) gene via promoter methylation impairs DNA repair mechanisms and is associated with improved treatment responses and extended overall survival in glioma patients treated with alkylating agents. This evidence concerns the gene MGMT and central nervous system cancer.